Chemotranscriptome analysis of synergism between D-chiroinositol and myoinositol in the context of postgenomic pharmacology

1. Громова О.А., Торшин И.Ю., Тетруашвили Н.К. Роли мио-инозитола в поддержании репродуктивного здоровья женщины. Повышение эффективности технологий экстракорпорального оплодотворения. РМЖ. Мать и дитя. 2018; 1: 88-95. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K. The role of myo-inositol in maintaining women's reproductive health. Improving the efficiency of in vitro fertilization technologies. Russian Medical Journal. Mother and Child. 2018; 1: 88-95. (in Russian)]. https://dx.doi.org/10.32364/2618-8430-2018-1-1-88-95.
2. Rapiejko P.J., Northup J.K., Evans T., Brown J.E., Malbon C.C. G-proteinsof fat-cells. Role in hormonal regulation of intracellular inositol 1,4,5-trisphosphate. Biochem. J. 1986; 240(1): 35-40. https://dx.doi.org/10.1042/bj2400035.
3. Salihu H.M., Dongarwar D., King L.M., Yusuf K.K., Ibrahimi S., Salinas-Miranda A.A. Phenotypes of fetal macrosomia and risk of stillbirth among term deliveries over the previous four decades. Birth. 2020; 47(2): 202-10.https://dx.doi.org/10.1111/birt.12479.
4. Ляличкина Н.А., Макарова Т.В., Салямова Л.Ш. Макросомия плода. Aкушерские и перинатальные исходы. Современные проблемы науки и образования. 2016; 3; 71. (Электронный научный журнал). Доступно по: http://www.science-education.ru/ru/article/view?id=24572[Lyalichkina N.A., Makarova T.V., Salyamova L.Sh. Macrosomia of the fetus. obstetric and perinatal outcomes. Modern problems of science and education. 2016; 3 (electronic scientific journal).Available at:http://www.science-education.ru/ru/article/view?id=24572 (in Russian)].
5. Громова О.А., Торшин И.Ю., Уварова Е.В., Тапильская Н.И., Калачева А.Г. Систематический анализ биологических ролей и фармакологических свойств D-хироинозитола. Гинекология. 2020; 22(3): 21-8. [Gromova O.A., Torshin I.Yu., Uvarova E.V., Tapilskaya N.I., Kalacheva A.G. Systematic analysis of the biological roles and pharmacological properties of D-chiroinositol. Gynecology. 2020; 22(3): 21-8. (in Russian)]. https://dx.doi.org/10.26442/20795696.2020.3.200210.
6. Торшин И.Ю., Майорова Л.А., Уварова Е.В., Тапильская Н.И., Громова О.А.Хемореактомный анализ стереоизомеров инозитола: различные профили фармакологического действия мио-инозитола и D-хиро-инозитола при нарушениях женской репродуктивной системы. Вопросы гинекологии, акушерства и перинатологии. 2020; 19(5): 57-69. [Torshin I.Yu.,Mayorova L.A., Uvarova E.V., Tapilskaya N.I., Gromova O.A. Chemoreactome analysis of stereoisomers of inositol: different profiles of the pharmacological action of myo-inositol and D-chiro-inositol in disorders of the female reproductive system. Issues of gynecology, obstetrics and perinatology. 2020; 19(5): 57-69. (in Russian)]. https://dx.doi.org/10.20953/1726-1678-2020-5-57-69.
7. Torshin I.Yu. Sensing the change: from molecular genetics to personalized medicine. Bioinformatics in the post-genomic era: the role of biophysics. New York: Nova Biomedical Books, cop. 2009.
8. Torshin I.Y., Rudakov K.V. On the application of the combinatorial theory of solvability to the analysis of chemographs: part 2. local completeness of invariants of chemographs in view of the combinatorial theory of solvability. Pattern Recognition and Image Analysis. 2014; 24(2): 196-208.
9. Торшин И.Ю., Громова О.А., Стаховская Л.В., Семенов В.А., Щукин И.А. Хемотранскриптомный анализ указывает на нейротрофические и нейромодулирующие эффекты молекулы цитиколина. Неврология, нейропсихиатрия, психосоматика. 2020; 12(4): 91-9. [Torshin I.Yu., Gromova O.A., Stakhovskaya L.V., Semenov V.A., Shchukin I.A. Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule. Neurology, Neuropsychiatry, Psychosomatics. 2020; 12(4): 91-9. (in Russian)]. https://dx.doi.org/10.14412/2074-2711-2020-4-91-99.
10. Торшин И.Ю., Громова О.А., Сардарян И.С., Федотова Л.Э. Сравнительный хемореактомный анализ мексидола. Журнал неврологии и психиатрии им. C.C. Корсакова. 2017; 117(1-2): 75-84. [Torshin I.Y., Gromova O.A., Sardaryan I.S., Fedotova L.E. Sravnitel'nyĭ khemoreaktomnyĭ analiz meksidola [A comparative chemoreactome analysis of mexidol]. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2017; 117(1-2): 75-83. (in Russian)]. https://dx.doi.org/10.17116/jnevro20171171275-84.
11. Marduel M., Ouguerram K., Serre V., Bonnefont-Rousselot D., Varret M. Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation. Hum. Mutat. 2013; 34(1): 83-7. https://dx.doi.org/10.1002/humu.22215.
12. Westerterp M., Berbee J.F., Rensen P.C. Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification. J. Lipid Res. 2007; 48(6): 1353-61. https://dx.doi.org/10.1194/jlr.M700024-JLR200.
13. Nichols W.C., Dwulet F.E., Liepnieks J., Benson M.D. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem. Biophys. Res. Commun. 1988; 156(2): 762-8. https://dx.doi.org/10.1016/s0006-291x(88)80909-4.
14. Тапильская Н.И., Сажина И.Н., Андреева М.Д., Сорокина О.В. Эффективность применения комбинации миоинозитола и D-хироинозитола в соотношении 5:1 с марганцем и фолиевой кислотой у пациенток репродуктивного возраста с нерегулярным менструальным циклом и ожирением. Гинекология. 2022; 24(2): 101-7. [Tapilskaya N.I., Sazhina I.N., Andreeva M.D., Sorokina O.V. The effectiveness of the combination of myoinositol and D-chiroinositol in a 5:1 ratio with manganese and folic acid in patients of reproductive age with irregular menstrual cycles and obesity. Gynecology. 2022; 24(2): 101-7. (in Russian)].
15. Обоскалова Т.А., Воронцова А.В., Звычайный М.А., Гущина К.Г., Майтесян М.М. Результаты применения комбинации миоинозитола и D-хироинозитола в соотношении 5:1 у женщин с синдромом поликистозных яичников. Гинекология. 2020; 22(6): 84-9. [Oboskalova T.A., Vorontsova A.V., Zvychainyi M.A., Gushchina K.G., Maitesian M.M. Results of treatment with myo-Inositol and D-chiroinositol combination in ratio 5:1 in women with polycystic ovary syndrome. Gynecology. 2020; 22(6): 84-9.(in Russian)]. https://dx.doi.org/10.26442/20795696.2020.6.200548.
16. Bonnet S., Archer S.L., Michelakis E.D. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007; 11(1): 37-51. https://dx.doi.org/10.1016/j.ccr.2006.10.020.
17. Deyev I.E., Sohet F., Vassilenko K.P., Petrenko A.G. Insulin receptor-related receptor as an extracellular alkali sensor. Cell Metab. 2011; 13(6): 679-89. https://dx.doi.org/10.1016/j.cmet.2011.03.022.
18. Edens W.A., Sharling L., Cheng G., Lambeth J.D. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J. Cell Biol. 2001; 154(4): 879-91. https://dx.doi.org/10.1083/jcb.200103132.
19. Cha J.Y., Maddileti S., Mitin N., Harden T.K., Der C.J. Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform. J. Biol. Chem. 2009; 284(10): 6227-40. https://dx.doi.org/10.1074/jbc.M803998200.
20. Citores L., Bai L., Sorensen V., Olsnes S. Fibroblast growth factor receptor-induced phosphorylation of STAT1 at the Golgi apparatus without translocation to the nucleus. J. Cell. Physiol. 2007; 212(1): 148-56. https://dx.doi.org/10.1002/jcp.21014.
21. Plotnikov A.N., Hubbard S.R., Schlessinger J., Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell. 2000; 101(4): 413-24. https://dx.doi.org/10.1016/s0092-8674(00)80851-x.
22. Tolbert W.D., Daugherty-Holtrop J., Gherardi E., Vande Woude G., Xu H.E. Structural basis for agonism and antagonism of hepatocyte growth factor. Proc. Natl. Acad. Sci. USA. 2010; 107(30): 13264-9. https://dx.doi.org/10.1073/pnas.1005183107.
23. Elabd C., Cousin W., Upadhyayula P., Chen R.Y., Chooljian M.S., Li J. et al. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat. Commun. 2014; 5: 4082.https://dx.doi.org/10.1038/ncomms5082.
24. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T. et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999; 103(1): 129-35. https://dx.doi.org/10.1172/JCI4165.
25. Калачева А.Г., Торшин И.Ю., Стельмашук Е.В., Генрихс Е.Е., Александрова О.П., Хаспеков Л.Г., Громова О.А. Нейропротекторное действие миоинозитола на клеточной модели глутаматного стресса как основа для профилактики нарушений внутриутробного развития головного мозга. Фармакокинетика и фармакодинамика. 2018; 3: 9-20. [Kalacheva A.G., Torshin I.Yu., Stelmashuk E.V., Genrikhs E.E., Aleksandrova O.P., Khaspekov L.G., Gromova O.A. Neuroprotective effect of myoinositol on the cellular model of glutamate stress as a basis for the prevention of intrauterine brain development disorders. Pharmacokinetics and Pharmacodynamics. 2018; 3: 9-20. (in Russian)]. https://dx.doi.org/10.24411/2587-7836-2018-10018.
26. Zuberi S.M., Eunson L.H., Hanna M.G. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain. 1999; 122(Pt 5): 817-25.https://dx.doi.org/10.1093/brain/122.5.817.
27. McKnight G.L., Karlsen A.E., Kowalyk S., Mathewes S.L., Sheppard P.O., O'Hara P.J., Taborsky G.J. Jr. Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes. 1992; 41(1): 82-7. https://dx.doi.org/10.2337/diab.41.1.82.
28. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J. et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 2004; 7(3): 221-8. https://dx.doi.org/10.1038/nn1188.
29. Shimizu S., Matsuzaki S., Hattori T., Kumamoto N., Miyoshi K., Katayama T., Tohyama M. DISC1-kendrin interaction is involved in centrosomal microtubule network formation. Biochem. Biophys. Res. Commun. 2008; 377(4): 1051-6. https://dx.doi.org/10.1016/j.bbrc.2008.10.100.
30. Rossignol P., Ho-Tin-Noe B., Vranckx R., Bouton M.C., Meilhac O.,Lijnen H.R. et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J. Biol. Chem. 2004; 279(11): 10346-56.https://dx.doi.org/10.1074/jbc.M310964200.
31. Delvaeye M., Noris M., De Vriese A., Conway E.M. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009; 361(4): 345-57. https://dx.doi.org/10.1056/NEJMoa0810739.
32. Merryweather-Clarke A.T., Cadet E., Bomford A., Robson K.J. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet. 2003; 12(17): 2241-7. https://dx.doi.org/10.1093/hmg/ddg225.
33. Ghavami S., Eshragi M., Ande S.R., Chazin W.J., Klonisch T., Halayko A.J. et al. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 2010; 20(3): 314-31. https://dx.doi.org/10.1038/cr.2009.129.
34. Gordon C.T., Petit F., Kroisel P.M., Jakobsen L., Amiel J. Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears. Am. J. Hum. Genet. 2013; 93(6): 1118-25.https://dx.doi.org/10.1016/j.ajhg.2013.10.023.

Received 07.08.2022

Accepted 11.09.2022